… SARS-CoV-2 Omicron lineage strains (BA.1, BA.1.1, and BA.2) of two monoclonal antibody
… AZD7442 [AstraZeneca] combination), which correspond to ones used to treat or prevent …

… antibodies are a promising therapy. A noncompeting pair of human neutralizing antibodies
(B38 and H4) blocking SARS-CoV-… antibodies, antibody combinations and bsAb using SARS-…

… -19 prevention, neutralizing monoclonal antibodies (mAbs), … severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2)… As prevalence of SARS-CoV-2 variants can differ by country …

… A broad range of both novel and repurposed therapies have been evaluated as potential
treatments for SARS-CoV-2 infection, to be used in combination with supportive care measures…

… of anti-SARS-CoV-2 monoclonal antibodies with optimized … to confer full protection against
SARS-CoV-2 challenge and for … exceedingly high doses or in combination with remdesivir 5 . …

… SARS-CoV-2 epidemic have showed resistance to antibody … identified two novel SARS-CoV-2
neutralizing antibodies (nAbs) … A combination or cocktail therapy with multiple nAbs might …

… SARS-CoV-2 spike, suggesting that it could be used effectively in combination with other
antibodies … Together, these results reveal a cross-protective epitope on the SARS-CoV-2 spike …

… anti-spike mAbs and combinations of mAbs against replicating VSV-SARS-CoV-2-S virus in
… anti-spike mAbs and combinations of mAbs against SARS-CoV-2-S virus in VeroE6 cells. …

… Lastly, we study C135 and C144, another antibody combination treatment currently on
phase 1 study. Due to fact that there is no 3D structure of C135 and C144 binding to RBD …

… For antibody combinations previously authorized or approved for clinical use, all showed
a substantial loss of activity in vitro against BA.2.12.1 and BA.4/5. As for a mAb directed to the …